-ethyl] carbamate) is an insect growth regulator used for long-term fire ant control. Because of its effects on insect reproduction and its potential use on pasturage consumed by food animals, a reproductive study was conducted using Rambouillet sheep. The sheep were dosed daily with a placebo or with fenoxycarb at 0.69 or 1.38 mg/kg/day, representing ten (10ϫ) and 20 times (20ϫ) the maximum amounts of fenoxycarb in forage or hay treated at recommended levels for fire ant control. Parameters that were measured included rates of weight gain of adults, serum clinical chemistry profiles of adults, spermatozoal morphology and motility, estrus cycling, pregnancy rates, maintenance of pregnancies to term, numbers of live births, and rates of weight gain of lambs to 28 days. There were no statistically significant (P Յ 0.05) differences between the exposed and control groups of sheep in any of these facets of the study. No clinical signs associated with exposure to fenoxycarb were observed in any animal at any time, and no exposure-related pattern of pathologic lesions or reproductive organ histology was observed. Means of hepatic fenoxycarb residues in the rams followed a statistically significant (P Յ 0.05) dose-related pattern. No fenoxycarb was detected (detection limit of 5 ppb) in any neonatal liver, despite the presence of hepatic fenoxycarb residues in the treated ewes, indicating that transplacental transport of fenoxycarb was minimal. No fenoxycarb was detected in any lamb liver at 28 days, although both the colostrum and the milk of exposed ewes were found to contain fenoxycarb at levels proportional to the treatments. Based on the lack of significant findings in this study, it is unlikely that use of fenoxycarb, according to label instructions (currently applicable to homeowner and registered agricultural usage) for fire ant control in pasturage or hay fields, will affect ruminant reproduction.
Fenoxycarb (ethyl [2-(4-phenoxyphenoxy)-ethyl] carbamate), a despite its structure, does not act as a carbamate cholinesterase inhibitor. 15 As an insect growth regulator, it strongly stimulates juvenile hormone activity, thus inhibiting molting and metamorphosis between growth stages (larvae, pupae, and adult) and also suppressing egg development. 9, 20, 21 Fenoxycarb is available in several sectors of the pest control market with demonstrated efficacy in the control of fire ants, [9] [10] [11] mosquitoes when it is applied to standing water, 21, 22 and cockroaches 16 and fleas 20 in laboratory situations. In the form of a granular bait on a defatted corn-cob grit base, 23 fenoxycarb is used by commercial pest control operators and homeowners to suppress the infiltration of fire ants (red imported fire ants, Solenopsis invicta) in urban and registered agricultural sites. Fenoxycarb thus far is not labeled for food animal pasture use, although the impact of fire ants has been noted by both cattle raisers 3 and wildlife management personnel. 3, 5 The ants swarm onto any animal that is on the ground for too long and can blind and even kill weak, newborn calves.
Acute oral LD 50 studies in rats with fenoxycarb at doses in excess of 2,000 mg/kg body weight produced nonspecific clinical signs including sedation, dyspnea, exophthalmos, diarrhea, ruffled fur, muscle spasms, tremor, and coma. Signs were reversible in surviving animals. 14 Teratology studies in rats 7 and rabbits 13 demonstrated no embryotoxic or teratogenic effects in animals dosed with fenoxycarb at critical points of fetal development. A 2-generation rat reproductive study 1, 2 found that no treatment-related changes in mortality, clinical condition, mating performance, fertility, litter size, neonate viability, growth, and physical or functional development occurred at any exposure level (0, 16, 47, or 140 mg/kg body weight). Adults at 140 mg/kg body weight of fenoxycarb experienced a transient decreased rate of gain, increased gonad weight without apparent functional effect or histologic correlate, and liver hypertrophy with focal necrosis. Liver weights were increased at the high and medium dose levels. Both F1 and F2 pup weights were reduced at all exposure levels, and there were statistically significant (P Յ 0.05) delays in pinna unfolding and eye opening. 1, 2 A no observable effect level (NOEL) of 3.4 mg/kg/day for rat pups was extrapolated from the doses used in this study. 19 Diagnosticians are already being presented with questions regarding the safety of fenoxycarb products for use with ruminants as ranchers and dairy farmers search for options for the suppression of fire ants. The treatment levels used in the rat reproductive study 1, 2 above are 200 to 2,000 times higher than exposure levels obtainable with commercially available formulations. Because of the critical nature of potential hormonal effects on production operations, this report investigates effects fenoxycarb may have on ruminant animals and their reproduction at more realistic exposure levels.
Materials and methods
Rationale for dose selection. The treatment levels for this study were based on the label rate for application of commercial fenoxycarb (1 to 1.5 lb/acre), a low average hay production (5,000 lb/acre), and three assumptions: 1) that all of the applied chemical was baled into the hay, 2) that no degradation occurred, and 3) that the animals ate 2.3% of their body weight per day of the treated hay. The maximum chronic amount of fenoxycarb that an animal might realistically consume under this worst-case scenario was 0.069 mg/kg body weight/day. This number was multiplied by 10 and 20 to arrive at the applied doses of 0, 0.69, and 1.38 mg/kg body weight/day. Preparation of doses. Fenoxycarb a is a tan, waxy, solid material at room temperature. For this study, solid fenoxycarb technical a (97.8% active ingredient) was grated to a fine powder and weighed into gelatin capsules. b Corn starch c was used to completely fill the capsules for each animal, masking the amount of fenoxycarb so that clinical observations were free of bias. Capsules and corn starch were human consumption grade and were not assayed for fenoxycarb prior to the study. Control animals received capsules containing only corn starch. Individual animal dosages were recalculated weekly based on the most recent body weights. Body weights were not corrected for fleece weight or fill state, since these varied considerably between individuals. Animals were dosed individually every day using a balling gun. d Study design. The study followed a modified Segment I 17 design (no interim kill), with all ewes and rams dosed for one estrus or spermatogenic cycle prior to breeding. The 24 commercial Rambouillet rams were yearlings from the same ranch and from similar parentage. Rams were divided into 3 treatment groups of 8 animals (Control [Ctrl], 10ϫ and 20ϫ), based on body weights and serum chemistry profiles, and were then dosed for 60 days (at least one spermatogenic cycle) prior to breeding. Each of the 40 commercial Rambouillet ewes was a proven 4 year old, having produced at least one lamb crop. All ewes were purchased from the same ranch and were of similar parentage. The ewes were divided into 5 treatment groups of 8 animals (2 Ctrl, 2 at 10ϫ, and 1 at 20ϫ) and were dosed for 20 days (at least 1 estrus cycle), during which they were encouraged to cycle by continuous exposure to a vasectomized ram. A 60-day breeding period immediately followed the prebreeding periods for both ewes and rams. Rams were rotated through the assigned ewe group pens ( Fig. 1 ) on a daily basis. Only the Ctrl and 10ϫ rams were used for breeding purposes because the probability of consumption of a 20ϫ dose of fenoxycarb is remote, and because prior studies in other species have not noted effects on male reproductive performance. 1, 2 At the end of the breeding period, and after exposure to fenoxycarb for 120 days, the rams were euthanized and necropsied. The ewes were dosed daily with fenoxycarb throughout the breeding period, their pregnancies, and for 28-30 days postpartum. Lambs born to these ewes received fenoxycarb only via their dams' milk. Colostrum was collected from each ewe within 24 hr of parturition, and milk was collected on postpartum day 7. Whenever twins occurred, one twin was euthanized before suckling to test for transplacental transfer of fenoxycarb. At or soon after 28 days postpartum, each ewe-lamb pair was euthanized and necropsied. Ewes were treated daily with fenoxycarb for 200 to 260 days. 6, 8, 12 Clinical monitoring. Animals were evaluated daily for clinical signs including inability to rise, anorexia, depression, limping or staggering, lacrimation, excessive salivation, unusual vocalization, scouring, isolation, respiratory distress, and star-gazing posture. Throughout the study, the serum chemistry profiles of all adult animals were determined e monthly. Scrotal circumferences and semen samples for motility and morphology evaluation 8 were taken from the rams biweekly. The ewes' serum progesterone (P4) levels f were monitored weekly throughout prebreeding, breeding, and gestation and were subjected to statistical comparison at 4-week intervals. All adult animals were weighed weekly and the body weights statistically analyzed at 4-wk intervals. All lambs were weighed on days 0, 4, 7, 14, 21, and 28, and crown-rump lengths were measured at birth. 6 Pathologic evaluation. Euthanasia of all adults was by electrocution; all lambs were euthanized by intracardial injection of sodium pentobarbital. g All livers and 1 ovary or testicle of each adult were weighed prior to any other sampling. Gross and microscopic pathologic examination followed standard practice, and tissue sets including brain, lung, liver, kidney, and ovary or testicle (and mammary or epididymis of adults) were fixed in 10% neutral buffered formalin. Tissue sections were stained with hematoxylin and eosin prior to evaluation. Spermatid reserve evaluations were performed on frozen testicular parenchyma. 8 Fenoxycarb assays. Livers were homogenized and stored at Ϫ20 C, as were milk and colostrum samples, prior to fenoxycarb assay. Duplicate 10-g aliquots of each tissue Figure 2 . No statistically significant differences were observed in body weight gain in rams (a), ewes (b), or lambs (c) during the study, although there appears to be a downward trend in lamb growth rates associated with increased parental exposure. Rams: all groups (n ϭ 8). Ewes: Ctrl (n ϭ 16), 10 ϫ (n ϭ 16), 20 ϫ (n ϭ 7). Lambs are grouped according to their dams' treatment levels, and all twins are excluded. Lambs: Ctrl (n ϭ 15), 10 ϫ (n ϭ 16), 20 ϫ (n ϭ 7). One lamb each from the Ctrl and 10 ϫ groups died between the 7and 14-day measurements. Ⅺ ϭ Control, c ϭ 10 ϫ, Ⅵ ϭ 20 ϫ.
were extracted and analyzed by column-switching 4 HPLC with photodiode array UV detection and spectral matching. h Statistical analyses. All numerical data were compared using Student-Newman-Keuls analysis of variance and a 95% confidence interval (P Յ 0.05) using SAS. i
Results
No clinical signs of fenoxycarb intoxication were observed in any animal at any time, nor were there any trends or abnormalities in clinical chemistry associated with fenoxycarb exposure in the mean profiles derived for each treatment group for either sex at any time during the study. No treatment-related pattern of pathologic lesions or abnormal reproductive organ histology was observed.
No statistically significant differences in mean body weights ( Fig. 2a ), scrotal circumferences, or evaluations of spermatozoal motility and morphology (data not shown) were observed among the 3 groups of rams. Testicular spermatid reserve, testicle/body weight ratio, and liver/body weight ratio also had no statistically significant differences (Table 1) .
Because no differences were measured among the ram groups, the ewes and lambs were evaluated according to the ewe dose levels only, giving a total of 16 ewes each for the Ctrl and 10ϫ groups, and 8 ewes for the 20ϫ group. No statistically significant differences in mean body weights (Fig. 2b ) or P4 levels (data not shown) were observed among the 3 ewe groups. Every ewe completed at least one estrus cycle prior to the breeding period, based on P4 measurements. Pregnancy rates, gestation lengths, and numbers of live births per pregnancy did not vary significantly among the ewe groups. Thirty-nine pregnancies were carried to term, including 11 pairs of twins, and there were no abortions or resorptions, based on P4 measurements and ultrasound. Although it was not statistically significant, the average number of births per ewe (Table 1) for the 10ϫ group was elevated from those of the control and 20ϫ groups by 83% of the range. One control ewe delivered at 165 days of gestation a stillborn lamb; gross examination revealed acromegaly, cervical lordosis, complete cleft palate, and an interventricular septal defect. At necropsy, the ewe groups had no statistically significant dose-related differences in ovary/body weight or liver/body weight ratios (Table 1 ).
There were no statistically significant differences among the lamb groups with respect to lamb weights at 0, 4, 7, 14, 21, and 28 days (Fig. 2c) , in lamb crown-rump measurement at birth, or in lamb viabilities evaluated at 0, 4, and 28 days ( Table 1 ). One lamb from the control group died of starvation attributed to mastitis in its dam, and 1 lamb from the 10ϫ group died from pneumonia, which was not attributed to the dam's treatment.
Mean liver fenoxycarb residues of the ram groups did have statistically significant (P Յ 0.05) dose-related differences by Student-Newman-Keuls analysis of variance. The liver, colostrum, and milk fenoxycarb residues of the 10ϫ and 20ϫ ewes were indistinguishable from each other statistically, but were significantly elevated compared to those of the control ewes. Neither neonatal nor 28-30-day-old lamb livers con- tained detectable fenoxycarb residues (detection limit ϭ 5 ppb, Table 2 ).
Discussion
Fenoxycarb acts in its target species as a hormone analog 9,20,21 rather than as an overt toxin, 15 and all levels at which rats in a 2-generation study 1, 2 were treated resulted in delayed maturation of the offspring. The sheep in this protocol were exposed to lower levels in the interest of determining by its potential effect on the lambs whether the hormonal toxicant was available in sufficient amount for its unknown mechanism of action even at the lower levels of exposure. Absence of decreased rate of gain ( Fig. 2a, 2b) , increased gonad to body weight ratio, or increased liver to body weight ratio in the rams or ewes (Table 1) indicated that the exposure levels chosen met the target criteria for a Segment I 17 study: that the treatment levels had no observable effect on adult sheep.
The reproductive soundness of the rams increased over the course of the treatment period (September to late December). Spermatozoal morphology was variable over the first 8 weeks of testing, but the mean normal morphology approached 100% in all 3 groups by mid-November, with deviations of less than 5% (data not shown). All 3 groups were housed in equally close visual, auditory, and olfactory proximity to the ewes. Mean spermatid reserves measured at necropsy followed a dose-related downward trend, but the differences among the 3 groups were not statistically significant ( Table 1 ). The apparent trend may have been due to the fact that the 20ϫ rams were only stimulated to ejaculate every other week, whereas the Ctrl and 10ϫ rams were in service every 8 days.
Progesterone levels in all 40 ewes cycled normally prior to conception, and there was no pattern to the number of ewes in each treatment group that failed to conceive at the first opportunity. Following concep-tion, the mean P4 levels followed the expected pattern, with increasing standard deviations in all groups toward the latter half of the pregnancies (data not shown). One ewe of the 20ϫ group did not conceive within the 60 day limit; necropsy revealed bilateral adhesions of the oviductal fimbria to the ovaries, interpreted as a physical block to conception, which was not attributed to fenoxycarb exposure. All 39 pregnancies were uneventful, and all lambs were delivered without human intervention.
A malformed, still-born lamb was carried by a control ewe and sired by a 10ϫ ram and represented 11.1% of the 9 lambs born to that 8-ewe unit. Prior studies in other species have not implicated fenoxycarb-treated sires in cases of malformed offspring, 1, 2 and when this lamb was considered as 1 of 19 lambs born to control ewes, the rate of congenital defects dropped to 5.3%. There were no other malformed or stillborn lambs among the 50 lambs produced by all combinations of parents within the study population, which converted the frequency of defects to 2%. Twotenths to 2% of lambs in commercial Rambouillet herds are born with congenital abnormalities. Almost half of lambs with interventricular septal defects have associated skeletal defects, including cleft palate and abnormal spinal curvature. 18 Therefore, it is highly unlikely that malformations present in a single lamb born to a control ewe were attributable to study conditions or fenoxycarb treatment.
The distribution of 7 sets of twins out of 11 total sets to the 10ϫ treatment group was likely due to small group sizes, but it does raise intriguing questions about potential hormonal activity of fenoxycarb within a restricted dose range. Five of the 7 sets of twins delivered from 10ϫ ewes were dizygotic based on lamb sex, as was the single set of twins born to a 20ϫ ewe. Three sets of twins were born to control ewes, and all pairs were same-sex (data not shown). A second experiment with larger group sizes would be required to either verify or negate the possibility that fenoxycarb might stimulate multiple ovulations.
The maternal exposures used in this study were approximately 100-fold lower than those to which the rat pups were exposed. 19 At 1.38 mg/kg/day parental exposure the lambs did not demonstrate low birth weights, decreased viability, or delayed maturation ( Table 1 ). The mean body weights of the lamb groups appeared to follow a dose-related pattern of decreased rate of gain after birth, but there were no statistically significant differences among the 3 groups (Fig. 2c) . Extension of the experiment beyond 28 days after birth would be required for resolution of the trend if the same treatment levels were employed.
Presence of fenoxycarb parent compound in the colostrum and milk of the exposed ewes indicated that fenoxycarb reached to general circulation unchanged ( Table 2 ). If a significant proportion of the maternal dose were able to cross the placenta, fenoxycarb should have been as detectable in the immature neonatal liver as it was in the corresponding maternal liver. No neonatal liver contained any fenoxycarb at a detection limit of 5 ppb ( Table 2) , indicating that fenoxycarb itself does not cross the placenta. Based on this, the apparent ability of fenoxycarb to delay maturation in the rat pups 1,2 at 100-fold higher exposure levels may have been due to a second messenger effect, as is the case with many hormonal agents. The fact that no fenoxycarb was detected (Ͻ5 ppb) in the livers of the 28-30-day-old lamb livers is not surprising, since their entire daily exposure came from the dams via the milk, and the mean daily dose was more than 1,000-fold lower than the ewes' treatments ( Table  2 ). Because its mechanism is unknown, it is unclear whether in utero exposure to fenoxycarb at a specific stage of gestation or continuous exposure throughout gestation and via suckling is responsible for the decreased rate of gain observed in rat pups 1,2 at 100-fold higher treatment rates and possibly the slight but statistically insignificant trend followed by the lambs in this study (Fig. 2c) .
The lack of treatment correlation among the mean liver, colostrum, and milk fenoxycarb residues of the 10ϫ and 20ϫ ewes and the wide standard deviation for each tissue indicate a wider range of interanimal variability in disposition of the drug in lactating females than was apparent in the rams ( Table 2 ). Availability of the secretory colostrum/milk compartment may have been the only factor affecting fenoxycarb distribution in the ewes, but sex-related differences in hormonal metabolism cannot be ruled out by this study. It would be useful to determine whether or not the pattern of liver fenoxycarb residues in nonlactating ewes mirrors the rams' well-demarcated 10ϫ and 20ϫ liver residues.
No treatment-related pattern of reproductive, physiologic, or behavioral abnormality was observed in Rambouillet sheep treated with fenoxycarb at 10 and 20 times potential exposure levels in pasture or hay from fields treated with current label rates of fenoxycarb for fire ant control. Based on the lack of signs or lesions of toxicity observed in sheep in these studies, reproductive or production losses caused by commercially available fenoxycarb formulations used at labeled rates are unlikely in ruminant species. 
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